Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss
British journal of surgery2013Vol. 100(10), pp. 1271–1279
Citations Over TimeTop 10% of 2013 papers
Abstract
TXA reduces blood loss in surgical patients by about one-third. A total dose of 1 g appears to be sufficient for most adults. There is no evidence to support the use of high doses.
Related Papers
- → Evaluation of Role of Tranexamic Acid in Reducing Blood Loss and Transfusion Rate in Patients Undergoing Lower Limb Orthopaedic Surgeries(2020)4 cited
- → Tranexamic Acid Reduces Intraoperative Blood Loss in Pediatric Patients Undergoing Scoliosis Surgery(2005)7 cited
- → Intra-operative tranexamic acid reduces blood loss and length of hospital stay after unilateral knee replacement surgery(2012)2 cited
- → CAN TOPICAL TRANEXAMIC ACID APPLICATION ON PUMP CORONARY ARTERY BYPASS GRAFT SURGERY REDUCE POSTOPERATIVE BLOOD LOSS(2018)
- → Comment on: "Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: A prospective clinical study"(2018)